Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines

Background: Lung-transplant (LT) recipients are at high risk for COVID-19 due to immunosuppression and respiratory tropism of SARS-CoV-2. The information on the effect of COVID-19 mRNA vaccines to elicit immunogenic responses after a two-dose (2D) regimen in LT recipients is sparse. Thus, we assesse...

詳細記述

書誌詳細

主要な著者:	Madhusudhanan Narasimhan, Lenin Mahimainathan, Andrew E Clark, Amena Usmani, Jing Cao, Ellen Araj, Fernando Torres, Ravi Sarode, Vaidehi Kaza, Chantale Lacelle, Alagarraju Muthukumar
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2021-06-01
シリーズ:	Vaccines
主題:	lung transplantation SARS-CoV-2 IgG IgM Spike nucleocapsid
オンライン･アクセス:	https://www.mdpi.com/2076-393X/9/7/708
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!